![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/06/Simeprevir-is-an-Orally-Active-HCV-NS34A-Protease-Inhibitor-2021-06-19.jpg)
Hepatitis C is a blood-borne infection that can ultimately result in severe liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma.…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/12/BMS-986144-is-a-Third-Generation-NS34A-Protease-Inhibitor-2020-01-07.jpg)
Hepatitis C virus (HCV) is a human pathogen with high morbidity. The HCV NS3/4A protease is essential for viral replication…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2020/06/HZ-1157-is-a-HCV-NS34A-Protease-Inhibitor-2020-07-01.jpg)
The major cause of chronic liver disease is the Hepatitis C virus (HCV). HCV is able to establish a chronic…